SB957
Prescription Drug Affordability Board and Fund; established, drug cost affordability review, etc.
Summary
As Passed House of Origin. Prescription Drug Affordability Board and Fund established; drug cost affordability review.
Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products.-
Bill History
- 01/06/2023 - Senate: Prefiled and ordered printed; offered 01/11/23 23100215D
- 01/06/2023 - Senate: Referred to Committee on Commerce and Labor
- 01/06/2023 - Senate: Introduced bill reprinted 23100215D
- 01/16/2023 - Senate: Reported from Commerce and Labor (11-Y 4-N)
- 01/16/2023 - Senate: Rereferred to Finance and Appropriations
- 01/26/2023 - Senate: Impact statement from DPB (SB957)
- 01/31/2023 - Senate: Senate committee, floor amendments and substitutes offered
- 01/31/2023 - Senate: Reported from Finance and Appropriations with amendments (13-Y 2-N)
- 02/01/2023 - Senate: Constitutional reading dispensed (40-Y 0-N)
- 02/02/2023 - Senate: Read second time
- 02/02/2023 - Senate: Reading of amendments waived
- 02/02/2023 - Senate: Committee amendments agreed to
- 02/02/2023 - Senate: Engrossed by Senate as amended SB957E
- 02/02/2023 - Senate: Printed as engrossed 23100215D-E
- 02/03/2023 - Senate: Read third time and passed Senate (25-Y 14-N) Close Floor Vote
- 02/03/2023 - Senate: Reconsideration of passage agreed to by Senate (38-Y 0-N)
- 02/03/2023 - Senate: Passed Senate (26-Y 13-N) Close Floor Vote
- 02/03/2023 - Senate: Impact statement from DPB (SB957E)
- 02/08/2023 - House: Placed on Calendar
- 02/08/2023 - House: Read first time
- 02/08/2023 - House: Referred to Committee on Commerce and Energy
- 02/13/2023 - House: Assigned sub: Special Subcommittee #5
- 02/16/2023 - House: Subcommittee recommends laying on the table (4-Y 2-N)
- 02/22/2023 - House: Left in Commerce and Energy
